(Q54312740)

English

In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.

scientific article published in November 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Staphylococcus epidermidis

object named as

Staphylococcus epidermidis

1 reference

based on heuristic

inferred from title

author name string

J G Barr

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

E T Smyth

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

G M Hogg

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

publication date

1 November 1990

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

9

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

11

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

804-809

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

https://scigraph.springernature.com/pub.10.1007/bf01967378

0 references

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1007%2FBF01967378

21 January 2018

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1007%2FBF01967378

21 January 2018

Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1007%2FBF01967378

21 January 2018

In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The estimation of the bactericidal power of the blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of teicoplanin with other antimicrobial agents against gram-positive aerobes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro studies of antibiotic combinations for multiply-resistant coagulase-negative staphylococci.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing resistance to antimicrobial drugs, and resistance typing in clinically significant strains of Staphylococcus epidermidis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01967378

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2150814

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54312740&oldid=1629414472"